Warszawski Uniwersytet Medyczny
- Address
- Żwirki i Wigury 61, 02-091 Warsaw, Poland
Immune System Diseases and Nutritional and Metabolic Diseases
At Warszawski Uniwersytet Medyczny, clinical research in these areas focuses on rare and inherited conditions, especially glycogenosis type Ib. The trials are designed to assess whether a new treatment approach can help manage disease-related complications while supporting overall metabolic health.
- Studying glycogenosis type Ib and its impact on neutropenia
- Evaluating a potential therapy for improving safety and tolerability in this rare disease
- Exploring links between immune function and metabolic disorders
This work reflects a strong interest in metabolism and immune-related disease, with a clear focus on improving care for patients with uncommon but serious conditions.
Virus Diseases and Health Care
Research at this medical university also examines how early vaccination may influence the future risk of type 1 diabetes in children with elevated genetic susceptibility. The goal is to better understand whether infection prevention can help reduce autoimmune disease development.
- Following children at increased genetic risk for type 1 diabetes
- Assessing the role of COVID-19 vaccination in early immune protection
- Testing whether vaccination may lower the chance of autoantibody formation
This line of research connects viral disease prevention with public health and early-life disease prevention, aiming to improve long-term outcomes through better understanding of immune risk.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Warszawski Uniwersytet Medyczny
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Empagliflozin for Neutropenia Management in Glycogen Storage Disease Type Ib Patients | Instytut Pomnik Centrum Zdrowia Dziecka | Phase II | Not Recruiting | Mar 2022 | Apr 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Empagliflozin | 1 | Unknown | 2022-03-03 | 2022-03-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.